Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Ibuprofen 200 mg Tablet Wyeth SpA., Aprilia (LT), Italy Act-3 Ibuprofen 200 mg Tablet, capsule shaped Wyeth SpA., Aprilia (LT), Italy Act-3 Sumatriptan succinate 140 mg equivalent to 100 mg sumatriptan base Tablet Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Imigran 100 Sumatriptan succinate 70 mg equivalent to 50 mg sumatriptan base Tablet Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Imigran 50 Ranitidine bismuth citrate 400 mg Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Pylorid Abciximab 2 mg/mL in 5 mL, 20 mL Injection, vial Centocor BV., Leiden, The Netherlands ReoPro Oestradiol 25 mg Implant Organon (Ireland) Limited, Swords, Co Dublin, Eire Riselle Salbutamol sulphate 240 mcg equivalent to 200 mcg salbutamol base per dose Powder, inhaled, oral Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Ventolin Accuhaler Dated this 4th day of November 1997. G. R. BOYD, Chief Adviser, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.
Publication Date
13 Nov 1997

Notice Number

1997-go7998

Page Number

3780